These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 25772416)
21. Effect of solubilizing agents on mupirocin loading into and release from PEGylated nanoliposomes. Cern A; Nativ-Roth E; Goldblum A; Barenholz Y J Pharm Sci; 2014 Jul; 103(7):2131-2138. PubMed ID: 24898012 [TBL] [Abstract][Full Text] [Related]
22. In vitro evaluation of porous carrier-based floating granular delivery system of orlistat. Jain SK; Agrawal GP; Jain NK PDA J Pharm Sci Technol; 2008; 62(4):292-9. PubMed ID: 19174957 [TBL] [Abstract][Full Text] [Related]
23. Psyllium and copolymers of 2-hydroxylethylmethacrylate and acrylamide-based novel devices for the use in colon specific antibiotic drug delivery. Singh B; Chauhan N; Kumar S; Bala R Int J Pharm; 2008 Mar; 352(1-2):74-80. PubMed ID: 18055144 [TBL] [Abstract][Full Text] [Related]
24. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin. Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924 [TBL] [Abstract][Full Text] [Related]
25. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac. Piyakulawat P; Praphairaksit N; Chantarasiri N; Muangsin N AAPS PharmSciTech; 2007 Nov; 8(4):E97. PubMed ID: 18181557 [TBL] [Abstract][Full Text] [Related]
26. Design and optimization of NSAID loaded nanoparticles. Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573 [TBL] [Abstract][Full Text] [Related]
27. Preparation and in vitro release of spray-dried chitosan microspheres for levofloxacin delivery. Cai J; Zhang Y; Du W; Nan K J Control Release; 2011 Nov; 152 Suppl 1():e70-1. PubMed ID: 22195935 [No Abstract] [Full Text] [Related]
28. Matrix type transdermal therapeutic system containing captopril: formulation optimization, in vitro and ex vivo characterization. Kerimoğlu O; Keskin E; Dortunç B; Anah S Acta Pol Pharm; 2013; 70(2):291-300. PubMed ID: 23614285 [TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit L100 and Eudragit L100-55 as potential carriers for oral controlled drug delivery. Moustafine RI; Margulis EB; Sibgatullina LF; Kemenova VA; Van den Mooter G Eur J Pharm Biopharm; 2008 Sep; 70(1):215-25. PubMed ID: 18691856 [TBL] [Abstract][Full Text] [Related]
30. A biorelevant in vitro release/permeation system for oral transmucosal dosage forms. Delvadia PR; Barr WH; Karnes HT Int J Pharm; 2012 Jul; 430(1-2):104-13. PubMed ID: 22486954 [TBL] [Abstract][Full Text] [Related]
31. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Wittaya-areekul S; Kruenate J; Prahsarn C Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331 [TBL] [Abstract][Full Text] [Related]
32. Phase Transited Asymmetric Membrane Capsule: A Means for Achieving Delayed and Controlled Osmotic Flow. Philip AK; Philip B Curr Drug Deliv; 2010 Jul; 7(3):230-7. PubMed ID: 20497101 [TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin. Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444 [TBL] [Abstract][Full Text] [Related]
34. A chitosan lactate/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation. Parodi B; Russo E; Caviglioli G; Baldassari S; Gaglianone N; Schito AM; Cafaggi S Drug Dev Ind Pharm; 2013 Dec; 39(12):1911-20. PubMed ID: 22681543 [TBL] [Abstract][Full Text] [Related]
35. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave. Wong TW; Nurjaya S Eur J Pharm Biopharm; 2008 May; 69(1):176-88. PubMed ID: 17980563 [TBL] [Abstract][Full Text] [Related]
36. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl. Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284 [TBL] [Abstract][Full Text] [Related]
37. Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties. Zeng N; Dumortier G; Maury M; Mignet N; Boudy V Int J Pharm; 2014 Jun; 467(1-2):70-83. PubMed ID: 24699353 [TBL] [Abstract][Full Text] [Related]
38. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method. Jelvehgari M; Atapour F; Nokhodchi A Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883 [TBL] [Abstract][Full Text] [Related]
39. Chitosan-bovine serum albumin-Carbopol 940 nanogels for mupirocin dermal delivery: ex-vivo permeation and evaluation of cellular binding capacity via radiolabeling. Ay Şenyiğit Z; Coşkunmeriç N; Çağlar EŞ; Öztürk İ; Atlıhan Gündoğdu E; Siafaka PI; Üstündağ Okur N Pharm Dev Technol; 2021 Oct; 26(8):852-866. PubMed ID: 34193003 [TBL] [Abstract][Full Text] [Related]
40. Vehicle effects on in vitro release of tiaprofenic acid from different topical formulations. Ozsoy Y; Güngör S; Cevher E Farmaco; 2004 Jul; 59(7):563-6. PubMed ID: 15231433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]